These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29976414)
1. Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity. Ma J; Xia Q; Fu PP; Lin G J Food Drug Anal; 2018 Jul; 26(3):965-972. PubMed ID: 29976414 [TBL] [Abstract][Full Text] [Related]
2. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts. Ma J; Li M; Li N; Chan WY; Lin G Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Yang M; Ruan J; Fu PP; Lin G Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561 [TBL] [Abstract][Full Text] [Related]
4. Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans. Ma J; Zhang W; He Y; Zhu L; Zhang C; Liu J; Ye Y; Zhuge Y; Lin G Arch Toxicol; 2021 Feb; 95(2):759-765. PubMed ID: 33210216 [TBL] [Abstract][Full Text] [Related]
5. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human. Zhu L; Zhang C; Zhang W; Xia Q; Ma J; He X; He Y; Fu PP; Jia W; Zhuge Y; Lin G Arch Toxicol; 2021 Oct; 95(10):3191-3204. PubMed ID: 34390356 [TBL] [Abstract][Full Text] [Related]
6. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity. Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272 [TBL] [Abstract][Full Text] [Related]
7. Correlation Investigation between Pyrrole-DNA and Pyrrole-Protein Adducts in Male ICR Mice Exposed to Retrorsine, a Hepatotoxic Pyrrolizidine Alkaloid. Zhu L; Xue J; He Y; Xia Q; Fu PP; Lin G Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737038 [TBL] [Abstract][Full Text] [Related]
8. Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans. Ruan J; Gao H; Li N; Xue J; Chen J; Ke C; Ye Y; Fu PP; Zheng J; Wang J; Lin G J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2015; 33(4):404-21. PubMed ID: 26398275 [TBL] [Abstract][Full Text] [Related]
9. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673 [TBL] [Abstract][Full Text] [Related]
10. Immunoassay approach for diagnosis of exposure to pyrrolizidine alkaloids. Li N; Zhang F; Lian W; Wang H; Zheng J; Lin G J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Jul; 35(3):127-139. PubMed ID: 28506107 [TBL] [Abstract][Full Text] [Related]
11. Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure. Ma J; Ruan J; Chen X; Li D; Yao S; Fu PP; Ye Y; Gao H; Wang J; Lin G Chem Res Toxicol; 2019 Jun; 32(6):1027-1039. PubMed ID: 31012303 [TBL] [Abstract][Full Text] [Related]
12. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids. Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523 [TBL] [Abstract][Full Text] [Related]
13. The toxicokinetic and metabolism of structurally diverse pyrrolizidine alkaloids in rats. To YC; Pan Y; Yan X; He Y; Lin G J Ethnopharmacol; 2024 Mar; 321():117390. PubMed ID: 37956911 [TBL] [Abstract][Full Text] [Related]
14. Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity. Ma J; Zhang C; He Y; Chen X; Lin G Arch Toxicol; 2022 Feb; 96(2):639-651. PubMed ID: 34792613 [TBL] [Abstract][Full Text] [Related]
15. Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids. He Y; Zhu L; Ma J; Lin G Arch Toxicol; 2021 Jun; 95(6):1917-1942. PubMed ID: 34003343 [TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis. Ruan J; Yang M; Fu P; Ye Y; Lin G Chem Res Toxicol; 2014 Jun; 27(6):1030-9. PubMed ID: 24836403 [TBL] [Abstract][Full Text] [Related]
17. Pyrrolizidine Alkaloid-Protein Adducts: Potential Non-invasive Biomarkers of Pyrrolizidine Alkaloid-Induced Liver Toxicity and Exposure. Xia Q; Zhao Y; Lin G; Beland FA; Cai L; Fu PP Chem Res Toxicol; 2016 Aug; 29(8):1282-92. PubMed ID: 27388689 [TBL] [Abstract][Full Text] [Related]
18. Protein cross-linking in primary cultured mouse hepatocytes by dehydropyrrolizidine alkaloids: Structure-toxicity relationship. Xiong F; Jiang K; Chen Y; Ju Z; Yang L; Xiong A; Wang Z Toxicon; 2020 Oct; 186():4-11. PubMed ID: 32687888 [TBL] [Abstract][Full Text] [Related]
19. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica. Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501 [TBL] [Abstract][Full Text] [Related]
20. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]